Application supported by positive results from pivotal phase III EAGLE-2 and EAGLE-3 trials26 March 2025 assigned as action date for FDA decisionGepotidacin could be the first in a new class of oral ...

New data to be shared on GSK’s RSV vaccine across different age groups of patients at increased risk • Efficacy data for gepotidacin in ...

In this feature we spoke to Michael J. Morris, MD, and Benjamin Garmezy, MD, on the future of radioligand therapy in patients ...

The following is a summary of “Cancer Risk Among Patients With Multiple Sclerosis: A 10-Year Nationwide Retrospective Cohort ...

This congenital defect can be so severe that it interferes with eating and breathing. But corrective surgery is sometimes an option.

According to Precedence Research, the global collagen market size is projected to be worth around USD 27.47 billion by 2034 and growing at a CAGR of 8.9% between 2024 and 2034. The Asia Pacific ...

SIMS Trial report regarding pain at 4 weeks Table 4: Coloplast Altis 522 Study Studies show that single-incision slin ...

Bayer BAYRY announced the submission of a supplemental new drug application (sNDA) to the FDA for darolutamide. The sNDA is ...

They included Koen Van Sumere, whose rape by priests as a teenager at a Catholic school forced him to undergo several urogenital operations. Recognised by the Church as a category 4 victim ...

Urogenital models are experimental systems that recreate aspects of human urogenital development, function or disease. They include animal models of gonad development and urogenital disease.

Neoadjuvant androgen deprivation therapy with or without Fc-enhanced non-fucosylated anti-CTLA-4 (BMS-986218) in high risk localized prostate cancer: a randomized phase 1 trial. September 25, 2024 ...

Despite surgical resection, many patients with muscle invasive urothelial carcinoma (MIUC) experience recurrence. Adjuvant immune checkpoint inhibition (ICI) following radical resection in patients ...